Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **neurotrophin pathway receptors** encompass a family of membrane-bound proteins that mediate the cellular actions of neurotrophins—secreted polypeptide growth factors critical for the development, maintenance, and plasticity of the nervous system[1][2][4][5][6]. The main families include the **tropomyosin receptor kinase (Trk) receptors** (TrkA/NTRK1, TrkB/NTRK2, TrkC/NTRK3), which are receptor tyrosine kinases, and the **p75 neurotrophin receptor** (p75NTR, NGFR), which is a member of the tumor necrosis factor (TNF) receptor superfamily[1][4][5]. Trk receptors preferentially bind mature neurotrophins with high affinity and transduce signals promoting neuronal survival, differentiation, and synaptic function, whereas p75NTR binds all neurotrophins and has context-dependent effects, including promoting apoptosis or enhancing Trk signaling[1][2][5][6]. These receptors are significant therapeutic targets, implicated in neurodegenerative diseases, cancers with NTRK gene fusions, nerve injury, and potentially psychiatric disease[1][2][3][4][5]. Drugs targeting Trk receptors are approved for cancers with NTRK fusions, while other strategies modulate their activity for neuroprotection or regeneration[8][9]. Because the term "Neurotrophin pathway receptors" aggregates several distinct receptors that differ in structure and biology, it is not the canonical name for a singular molecule; instead, **TrkA receptor, TrkB receptor, TrkC receptor, and p75 neurotrophin receptor** should be treated separately for structured annotation[1][2][4][5].
Agonists (e.g., neurotrophins, DHEA) activate receptor signaling and promote survival or, in some contexts, apoptosis (especially for p75NTR); Antagonists or inhibitors (such as NTRK inhibitors) block downstream signal transduction, suppressing tumor growth or aberrant neuronal signaling
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurotrophin pathway receptor.